Abstract
Purpose
Patients with gallbladder cancer (GBC) have a dismal prognosis. We investigated outcomes and risk factors for overall survival (OS) in patients treated with radical surgery and adjuvant chemoradiotherapy (CRT).
Materials/methods
A total of 212 patients with LAGC (⩾pT3 59% and/or pN+ 52%) were studied. The primary endpoint of the analysis was OS. We constructed a risk scoring system in which points were assigned to each risk factor by dividing each β coefficient in the final model by the lowest β coefficient and rounding to the nearest integer. A risk score was assigned to each subject by adding up the points for each risk factor present. Subjects were then divided into three risk groups based on their risk scores (0 points = low risk, 1–2 points = intermediate risk, 3–6 points = high risk).
Results
Median follow-up was 46.2 months (2–235). Five-year OS for the entire cohort was 53%. In multivariate analysis, higher pT stage [HR, 2.43 (1.29–3.68); p = 0.01], R1 resection [HR, 5.06 (3.12–8.19); p < 0.001], and number of surgical procedures [HR, 1.41 (1.01–2.16); p = 0.05] were associated with an increased risk of death. Five-year OS for patients with low (n = 63), intermediate (n = 94), and high (n = 55) risk was 79.1%, 51.2%, and 9.5%, respectively.
Conclusion
Overall results after multimodality treatment of GBC are promising. A risk model was generated to determine a prognostic index for individual patients with GBC. Classification of risk factors for death has contributed to propose a prognostic index that could allow us to guide risk-adapted tailored treatment.
Similar content being viewed by others
References
Siege RL, Miller KD, Jemal A (2015) Cancer statistics, 2015. CA Cancer J Clin 65:5–29
Hundal R, Shaffer (2014) Gallbladder cancer: epidemiology and outcome. Clin Epidemiol 6:99–109
D’Angelica M, Moore Dalal K, DeMatteo R et al (2009) Analysis of the extent of resection for adenocarcinoma of the gallbladder. Ann Surg Oncol 16:806–816
Wang S, Lemieux A, Kalpathy-Cramer J (2011) Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer. J Clin Oncol 29:4627–4632
Czito B, Hurwitz H, Clough R (2005) Adjuvant external-beam radiotherapy with concurrent chemotherapy after resection of primary gallbladder carcinoma: a 23-year experience. Int J Radiation Oncology Biol Phys 62(4):1030–1034
Kresl J, Schild S, Henning G (2002) Adyuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma. Int. J. Radiation Oncology Biol. Phys. 52(1):167–175
Kim Y, Amini N, Wilson A (2016) Impact of chemotherapy and external-beam radiation therapy on outcomes among patients with resected gallbaldder cancer: a multi- institutional analysis. Ann Surg Oncol Published online 11 May 2016. https://doi.org/10.1245/s10434-016-5262-8
Ben-Josef E, Guthrie KA, El-Khoueiry AB (2015) SWOG S0809: a phase II intergroup trial of adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and gallbladder carcinoma. J Clin Oncol 33(24):2617–2622
Baeza MR, Reyes JM, del Castillo C, Rivera R (2005) Post-operative adjuvant radiochemotherapy in the treatment of gallbladder cancer [Abstract]. Int J Radiat Oncol Biol Phys 63(Suppl):S285–S286
Concato J, Feinstein AR, Holford TR (1993) The risk of determining risk with multivariable models. Ann Intern Med 118:201–210
Mojica P, Smith D, Ellenhorn J (2007) Adyuvant radiation therapy is associated with improved survival for gallbladder carcinoma with regional metastatic disease. J Surg Oncol 96:8–13
Duffy A, Capanu M, Abou-Alfa GK, Huitzil D, Jarnagin W, Fong Y, D’Angelica M, DeMatteo RP, Blumgart LH, O’Reilly EM (2008) Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). Jour Surg Oncol 98:485–489
Kim K, Chie EK, Jang J-Y (2012) Postoperative chemoradiotherapy for gallbladder cancer. Strahlenther Onkol 188:388–394
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
No funding was received for this study.
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in the study were in accordance with the ethical standards of the national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sole, C.V., Vargas, L., Sole, V.J. et al. Adjuvant chemoradiation in resected gallbladder cancer: a prognostic index model for predicting overall survival. J Radiat Oncol 8, 157–162 (2019). https://doi.org/10.1007/s13566-019-00382-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13566-019-00382-2